$69.0 Million
Zafgen, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$46.0 Million
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$57.5 Million
Synlogic, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$69.0 Million
Adverum Biotechnologies, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$46.0 Million
Fate Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.0 Million
ImmunoVaccine (IMV, Inc.)
At the Market Offering
Active Bookrunner
$30.0 Million
ImmunoVaccine (IMV, Inc.)
At the Market Offering
Active Bookrunner
$143.8 Million
Paragon 28, Inc.
Initial Public Offering
Active Bookrunner
$3.3 Billion
Avantor, Inc.
Initial Public Offering
Active Bookrunner
$85.0 Million
SilverSpikeInvestment
Silver Spike Investment Corp
Initial Public Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.